Coalition to Accelerate and Support Prevention Research (CASPR)


The objective of this project is to bolster the development and longevity of an Africa-centered network dedicated to promoting advocacy, policy formulation, regulatory compliance, community involvement, and communication initiatives that facilitate the advancement of biomedical HIV prevention research. Here are the specific aims:

  1. Advocacy: Foster a knowledgeable and influential advocacy movement focused on prevention research and its implementation across all stakeholder tiers, from civil society advocacy to political leadership.
  2. Research Translation: Tailor messages and materials to various audiences, articulating the narrative of prevention research as it progresses.
  3. Research Preparedness: Facilitate the prompt and ethical execution of biomedical prevention trials, which is the core focus of Wits RHI’s GPP efforts.
  4. Policy Engagement: Position research as pertinent and indispensable in global, regional, and national dialogues concerning strategies aimed at ending the HIV epidemic.


  • Prof Sinead Delany-Moretlwe
  • AVAC (Prime lead)
  • Advocacy for Prevention of HIV/AIDS (APHA)
  • HIV Vaccine Trials Network (HVTN)
  • International AIDS Vaccine Initiative (IAVI)
  • InterNews
  • National AIDS Control Council of Kenya (NACC)
  • New HIV Vaccines and Microbicides Advocacy Society (NHVMAS)
  • WACI Health

Latest Update

April 2024

For more details about CASPR please email

Click here for further details regarding the CASPR study.

Stay up to date

Get updates on news, resources, events and happenings from Wits RHI.